Sign in
0QZM Stock Price, Chart, Stats & News
Alexion Pharmaceuticals, Inc.
Save
Alexion Pharmaceuticals, Inc. (0QZM) does not currently pay a dividend.
–
Market cap
38.74x
Current P/E
–
Forward P/E
0QZM chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Alexion Pharmaceuticals, Inc. specializes in creating and bringing to market a range of innovative medical treatments. Its commercial portfolio includes ULTOMIRIS (ravulizumab-cwvz), a C5 inhibitor designed to address paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Another key offering is SOLIRIS (eculizumab), a monoclonal antibody effective against PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD).
Similar securities
Based on sector and market capitalization
Report issue